Amyris (AMRS) Enters Alternative Cell Lines Development Agreement with Biogen (BIIB)
Tweet Send to a Friend
Amyris, Inc. (Nasdaq: AMRS) announced it has entered into a funded partnership with Biogen, Inc. (Nasdaq: BIIB). The collaboration will ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
